New product: Adynovi (rurioctocog alfa pegol) 1000 IU powder and solvent for solution for injection 2 ml solvent

Rurioctocog alfa pegol, a pegylated recombinant human factor VIII with an extended half-life, is licensed for the treatment and prophylaxis of bleeding in patients 12 years and above with haemophilia A (congenital factor VIII deficiency).

electronic Medicines compendium